VSBC (VitaSpring Biomedical Co) EV-to-EBIT : 2,805.29 (As of Jul. 24, 2025)

VitaSpring Biomedical Co EV-to-EBIT Chart

VitaSpring Biomedical Co Quarterly Data
	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22
EV-to-EBIT	Get a 7-Day Free Trial															-64,027.08	1,949.86	1,877.66	2,784.26	2,603.67

Competitive Comparison of VitaSpring Biomedical Co's EV-to-EBIT

For the Biotechnology subindustry, VitaSpring Biomedical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VitaSpring Biomedical Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VitaSpring Biomedical Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where VitaSpring Biomedical Co's EV-to-EBIT falls into.

VitaSpring Biomedical Co EV-to-EBIT Calculation

VitaSpring Biomedical Co's EV-to-EBIT for today is calculated as:

VitaSpring Biomedical Co's current Enterprise Value is $3,304.63 Mil.
VitaSpring Biomedical Co's EBIT for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VitaSpring Biomedical Co  (OTCPK:VSBC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

VitaSpring Biomedical Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2022 is calculated as:

VitaSpring Biomedical Co's Enterprise Value for the quarter that ended in Oct. 2022 was $3,067.13 Mil.
VitaSpring Biomedical Co's EBIT for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VitaSpring Biomedical Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of VitaSpring Biomedical Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

VitaSpring Biomedical Co Business Description